Free Trial

Opposition to Challenge Zuma Release on Medical Parole, Covid Cases Decline 26% W/W

SOUTH AFRICA

LOCAL NEWS

  • Political parties and civil rights groups are challenging the early release of Jacob Zuma on medical parole.
    • On Sunday, it was announced that Zuma would be released on medical parole due to undisclosed medical conditions.
    • He served only 58 days of his 15-month sentence for being in contempt of the Constitutional Court. Parties and groups are now planning legal action and other processes to either get the parole reversed or fully disclose the purported medical problems that allowed it to happen
  • Energy regulator Nersa has put to rest the bold claims that South Africa's 2,500MW nuclear build is back in action and forging ahead.
    • While the Department of Mineral Resources and Energy said last week that Nersa had concurred with its plans to proceed with the nuclear build, minutes released from the meeting by Nersa show that the regulator's concurrence is conditional and that several suspensive conditions have not yet been met.
    • In effect, Nersa is on board with the very start of the process, not a call for proposals for a new nuclear build. Energy expert Chris Yelland says no nuclear procurement will happen until govt has updated the Integrated Resources Plan (IRP)
  • CSIR says SA is seeing a promising decline in confirmed Covid cases with the third wave receding 26% on week. Medical experts say this is a real decline and not due to lower testing. SA reported 5,931 new cases & 76 deaths
MNI London Bureau | +44 020-3983-7894 | murray.nichol@marketnews.com
MNI London Bureau | +44 020-3983-7894 | murray.nichol@marketnews.com

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.